Social Media Ideas for Ai Biotech

Exclusive-Anthropic quietly sets up biology lab as it ramps AI drug program

AI Biotech Iambic Gets $150M in IPO Cash for ‘Molecular Superintelligence’ Drug R&D

Iambic Therapeutics, an AI-enabled biotech company, will apply the IPO proceeds toward clinical development of its pipeline of internally discovered and wholly owned cancer drugs....

ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’

Rather than deplete malfunctioning B cells as many other emerging autoimmune drugs do, Ai3Bio’s therapies are designed to eliminate a particular group of T helper cells.

Iambic, an AI drug discovery specialist, banks $150M in an IPO

Part of a wave of young biotechs employing AI to accelerate research, the company claimed in regulatory filings that its approach has the potential to “disrupt legacy drug discover...

Quantum Optimization and AI to Develop Alzheimer’s Drugs

INmune Bio (Nasdaq: INMB) and Quantum Computing Inc. (Nasdaq: QUBT) announced they are working togther to run INmune Bio’s clinical and preclinical data on XPro (XPro1595) through...

IMULIFE Announces AI Initiative to Track Immune Biomarkers Over Time

The IT-X framework is designed to compare blood-based immune data across repeated measurements

<![CDATA[Roundup: AbbVie & Iambic Enter Ai Drug Discovery Collaboration, Telix Merges with ITM ]]>

<![CDATA[Pharmaceutical Executive Daily: AbbVie Forms Ai-Powered Drug Discovery Partnership with Iambic]]>

<![CDATA[The Agentic AI Revolution in Biopharma]]>

AI-driven drug discovery race: Anthropic quietly opens biology laboratory in major push

While many AI companies rely exclusively on public datasets and external academic partnerships to train computational models, running an in-house laboratory allows researchers to p...

Anthropic sets up wet lab as it expands AI drug program

SAN FRANCISCO >> Anthropic has quietly set up a laboratory to do physical biology work as it pushes its artificial-intelligence ambitions into the world of drug science.

<![CDATA[Roundup: Alcon Acquires Neurotech and Encelto, Ai Proteins Enters Research Collaboration and License Agreeme...

Knowtex launches frontier healthcare AI lab

Knowtex initially began in oncology, but its platform now extends across more than 200 specialties at more than 300 organizations nationwide, executives say.

MindBio completes AI impairment screening kiosk, targets pilot this year

MindBio Therapeutics Corp. has completed manufacturing a kiosk designed to identify potential drug or alcohol impairment by analyzing a person's voice, according to a press release...

HISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES

SINGAPORE, Oct. 18, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), S...

The $275 Million Patient of the Future

Ian reveals how AI is ehancing drug research, and why the first person to receive tomorrow’s newest medicine might not be human at all.

Consolidating Antibody Discovery Data with an AI Platform

The Sapio Scientific AI platform gives scientists a single, structured environment where experimental records connect directly to client deliverables and where time spent on data c...

Ex-Genentech, Meta, AWS AI leaders launch health AI lab with $500M backing

The AI startup, Ortet, plans to build a full-stack platform for health, spanning computer and data infrastructure, frontier research, and model development and deployment.

Immunology Startup ai3Bio Aims to Redefine What It Means to Reset the Immune System

While the immune reset field is mainly focused on depleting pathogenic B cells, ai3Bio is applying its novel approach to inflammatory T cells. The startup’s initial disease targets...

<![CDATA[The AI Implementations That Produce Real Business Value]]>

Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development

BioAge Labs, Inc. (BIOA) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Anthropic quietly sets up biology lab as it ramps AI drug program

Anthropic has quietly opened a physical biology laboratory in the San Francisco Bay Area as it pushes its artificial intelligence work into drug science. The wet lab, confirmed by...

Chart of the Week: AI Is Unlocking a New Era of Discovery

Are Ian’s AI biotech stories isolated breakthroughs or the start of something bigger? This week’s chart offers a compelling answer.